Tumor-Associated Macrophages Write the Script of Cancer Obesity Paradox

Area of Science:

• Immunology
• Oncology
• Metabolic research

Background:

• Obesity is linked to increased cancer progression.
• Obesity can paradoxically enhance the efficacy of certain immunotherapies, such as anti-PD-1/PD-L1.
• Tumor-associated macrophages (TAMs) play a critical role in the tumor microenvironment.

Purpose of the Study:

• To investigate the mechanisms by which obesity affects anti-tumor immunity.
• To understand how obesity influences the expression of PD-1 on TAMs.
• To determine the impact of anti-PD-1 therapy on obesity-driven metabolic dysfunction in TAMs.

Main Methods:

• Analysis of TAMs in obese and non-obese cancer models.
• Assessment of PD-1 expression on TAMs.
• Evaluation of metabolic profiles of TAMs.
• Investigation of anti-PD-1 therapy's effects on TAMs and anti-tumor responses.

Main Results:

• Obesity-driven factors significantly increase PD-1 expression on TAMs.
• Elevated PD-1 on TAMs suppresses anti-tumor immune responses.
• Anti-PD-1 therapy effectively reverses this obesity-induced metabolic dysfunction in TAMs.
• Reactivation of PD-1+ TAMs by anti-PD-1 therapy boosts immune checkpoint blockade efficacy.

Conclusions:

• Obesity promotes cancer progression and impairs anti-tumor immunity via PD-1 upregulation on TAMs.
• Anti-PD-1 therapy can overcome obesity-associated immunosuppression by restoring TAM function.
• Targeting TAMs in obese cancer patients may enhance immunotherapy outcomes.